These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 38052538)

  • 1. Markov modeling and performance analysis of infectious diseases with asymptomatic patients.
    Li QL; Wang C; Yang F; Zhang C
    Math Biosci Eng; 2023 Sep; 20(10):17822-17848. PubMed ID: 38052538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A data-driven Markov process for infectious disease transmission.
    Wang C; Mustafa S
    PLoS One; 2023; 18(8):e0289897. PubMed ID: 37561743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic, Presymptomatic, and Asymptomatic Transmission of SARS-CoV-2 in a University Student Population, August-November 2020.
    Krieg SJ; Schnur JJ; Miranda ML; Pfrender ME; Chawla NV
    Public Health Rep; 2022; 137(5):1023-1030. PubMed ID: 35848117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.
    Furukawa NW; Brooks JT; Sobel J
    Emerg Infect Dis; 2020 Jul; 26(7):. PubMed ID: 32364890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing required SARS-CoV-2 blanket testing rates for possible control of the outbreak in the epicentre Lusaka province of Zambia with consideration for asymptomatic individuals: A simple mathematical modelling study.
    Sichone J; Sinkala M; Munsaka S; Kikonko M; Simuunza M
    PLoS One; 2021; 16(4):e0249479. PubMed ID: 33822785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Asymptomatic and Presymptomatic Transmission in SARS-CoV-2 Outbreak, Germany, 2020.
    Bender JK; Brandl M; Höhle M; Buchholz U; Zeitlmann N
    Emerg Infect Dis; 2021 Apr; 27(4):1159-63. PubMed ID: 33600301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probability of a disease outbreak in stochastic multipatch epidemic models.
    Lahodny GE; Allen LJ
    Bull Math Biol; 2013 Jul; 75(7):1157-80. PubMed ID: 23666483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases.
    Byrne AW; McEvoy D; Collins AB; Hunt K; Casey M; Barber A; Butler F; Griffin J; Lane EA; McAloon C; O'Brien K; Wall P; Walsh KA; More SJ
    BMJ Open; 2020 Aug; 10(8):e039856. PubMed ID: 32759252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographically dependent individual-level models for infectious diseases transmission.
    Mahsin MD; Deardon R; Brown P
    Biostatistics; 2022 Jan; 23(1):1-17. PubMed ID: 32118253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transmission of SARS-CoV-2 through contact with a SARS-CoV-2-infected individual in the presymptomatic or asymptomatic state in Japan: A case series].
    Tanaka H; Ogata T; Morisada K; Tanaka S; Yoshida T; Nakanishi H; Misawa A; Nishida T; Tetsu O; Nagata M; Nakazato E
    Nihon Koshu Eisei Zasshi; 2021 Aug; 68(8):550-558. PubMed ID: 33994491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A data-driven semi-parametric model of SARS-CoV-2 transmission in the United States.
    Drake JM; Handel A; Marty É; O'Dea EB; O'Sullivan T; Righi G; Tredennick AT
    PLoS Comput Biol; 2023 Nov; 19(11):e1011610. PubMed ID: 37939201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review.
    Jefferson T; Spencer EA; Brassey J; Onakpoya IJ; Rosca EC; Plüddemann A; Evans DH; Conly JM; Heneghan CJ
    Clin Microbiol Infect; 2022 Feb; 28(2):178-189. PubMed ID: 34757116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing.
    Liu XX; Yang J; Fong S; Dey N; Millham RC; Fiaidhi J
    Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
    Buitrago-Garcia D; Egli-Gany D; Counotte MJ; Hossmann S; Imeri H; Ipekci AM; Salanti G; Low N
    PLoS Med; 2020 Sep; 17(9):e1003346. PubMed ID: 32960881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global analysis and prediction scenario of infectious outbreaks by recurrent dynamic model and machine learning models: A case study on COVID-19.
    Rakhshan SA; Nejad MS; Zaj M; Ghane FH
    Comput Biol Med; 2023 May; 158():106817. PubMed ID: 36989749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.
    Li F; Li YY; Liu MJ; Fang LQ; Dean NE; Wong GWK; Yang XB; Longini I; Halloran ME; Wang HJ; Liu PL; Pang YH; Yan YQ; Liu S; Xia W; Lu XX; Liu Q; Yang Y; Xu SQ
    Lancet Infect Dis; 2021 May; 21(5):617-628. PubMed ID: 33476567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients.
    Chen Y; Li P; Ding Y; Liu M; Liu L; Yi B; Wu T; Dong H; Lao X; Ding K; Wang H; Zhang D; Tan X; Wang Z; Xu G; Cao G
    J Infect Public Health; 2021 Jul; 14(7):845-851. PubMed ID: 34118734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.